FBRX

Latest SEC Filings & News for FBRX

2 most recent filings and news items mentioning FBRX. Updated every 60 seconds.

Get this data via API — free tier: 10,000 calls/day

curl "https://api.brieftape.com/v1/tickers/FBRX/news?limit=20"

Pull FBRX filings straight into your trading bot, model, or app.

Get an API key — free tier: 10,000 calls/day

OtherJul 9, 2026Positive

Forte Biosciences' FB102 achieves statistically significant results in phase 1b vitiligo trial

Forte Biosciences announced positive results from a double-blind placebo-controlled study where FB102 improved vitiligo severity by 29.6% through week 24. Continued post-treatment efficacy and safety support the drug's therapeutic potential.

View filing at SEC.gov →

OtherJun 2, 2026Neutral

Forte Biosciences amends 2021 equity incentive plan effective April 28, 2026.

Forte Biosciences adopted an amended and restated 2021 equity incentive plan to provide equity awards to employees, directors, and consultants. The plan update may impact future compensation structures and shareholder dilution for the bioscience company.

View filing at SEC.gov →

AI-summarized public filings for informational purposes only. Not investment advice. Always verify against the original filing at sec.gov. BriefTape is not a registered investment adviser, broker-dealer, or financial advisor.